1. Home
  2. BLCO vs TGLS Comparison

BLCO vs TGLS Comparison

Compare BLCO & TGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • TGLS
  • Stock Information
  • Founded
  • BLCO 1853
  • TGLS 1984
  • Country
  • BLCO Canada
  • TGLS Colombia
  • Employees
  • BLCO N/A
  • TGLS N/A
  • Industry
  • BLCO Ophthalmic Goods
  • TGLS Electronic Components
  • Sector
  • BLCO Health Care
  • TGLS Consumer Discretionary
  • Exchange
  • BLCO Nasdaq
  • TGLS Nasdaq
  • Market Cap
  • BLCO 4.0B
  • TGLS 3.9B
  • IPO Year
  • BLCO 2022
  • TGLS 2012
  • Fundamental
  • Price
  • BLCO $11.87
  • TGLS $68.32
  • Analyst Decision
  • BLCO Hold
  • TGLS Buy
  • Analyst Count
  • BLCO 12
  • TGLS 5
  • Target Price
  • BLCO $18.64
  • TGLS $75.40
  • AVG Volume (30 Days)
  • BLCO 906.7K
  • TGLS 471.9K
  • Earning Date
  • BLCO 04-30-2025
  • TGLS 05-08-2025
  • Dividend Yield
  • BLCO N/A
  • TGLS 0.90%
  • EPS Growth
  • BLCO N/A
  • TGLS N/A
  • EPS
  • BLCO N/A
  • TGLS 3.43
  • Revenue
  • BLCO $4,791,000,000.00
  • TGLS $890,181,000.00
  • Revenue This Year
  • BLCO $6.43
  • TGLS $12.45
  • Revenue Next Year
  • BLCO $5.59
  • TGLS $8.59
  • P/E Ratio
  • BLCO N/A
  • TGLS $19.44
  • Revenue Growth
  • BLCO 15.56
  • TGLS 6.83
  • 52 Week Low
  • BLCO $10.46
  • TGLS $40.94
  • 52 Week High
  • BLCO $21.69
  • TGLS $86.99
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 36.46
  • TGLS 46.72
  • Support Level
  • BLCO $10.46
  • TGLS $66.49
  • Resistance Level
  • BLCO $12.38
  • TGLS $73.44
  • Average True Range (ATR)
  • BLCO 0.92
  • TGLS 3.95
  • MACD
  • BLCO -0.09
  • TGLS 0.03
  • Stochastic Oscillator
  • BLCO 33.02
  • TGLS 55.20

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About TGLS Tecnoglass Inc.

Tecnoglass Inc designs, manufactures, distributes, and markets architectural glass and windows. The company's products portfolio includes tempered, laminated, insulating and Solar Control Low-E glass. Its products are installed at hotels, residential buildings, commercial and corporate centers, airports and hospitals as floating facades, curtain walls, windows, doors, handrails, interior and dividers. Its majority of revenue is derived from the sale and installation of architectural glass and windows in the United States.

Share on Social Networks: